Literature DB >> 9561592

In vitro sensitivity of Plasmodium falciparum to eight antimalarials in China-Myanmar and China-Lao PDR border areas.

H L Yang1, D Q Liu, Y M Yang, K G Huang, Y Dong, P F Yang, M Z Liao, C Y Zhang.   

Abstract

In 1991-1995 by using the Rieckmann in vitro micro-method, susceptibilities of Plasmodium falciparum to eight antimalarials in the China-Lao PDR and China-Myanmar border areas were tested. The resistant rates of P. falciparum to chloroquinine were 95.0%-100%; IC50 114-240nmol/l. P. falciparum resistant rates to amodiaquine resistance accounted for 83.5%-100%, IC50 52-72nmol/l. All cases were sensitive to quinine, IC50 470-608nmol/l. P. falciparum isolates from the Lao PDR frontier were highly sensitive to artesunate, dihydroartemisinin, and arteether. Resistant rates from other areas were 0-11%. P. falciparum from China-Myanmar and Lao PDR border areas were also sensitive to mefloquine, IC50 68-88nmol/l. A longitudinal survey of the sensitivity of P. falciparum in vivo on the China-Lao PDR border showed that the average defervescent time of falciparum malaria was treated by pyronaridine increased from 32.7 +/- 16.0 hours during 1984-85 to 56.2 +/- 27.4 hours in 1995; the recrudescence rate rose up from 15.2% to 37.5%. The results monitored in vitro showed that all cases assessed in 1988 for response to pyronaridine were sensitive, but 36.4% of cases had emerging resistance, IC50 increased from 13nmol/l to 40 nmol/l. The above results suggested that P. falciparum in these areas has expressed resistance to chloroquine and amodiaquine. However, the parasites are still sensitive to artemisinin, pyronaridine, mefloquine, quinine, but with a declining sensitivities.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9561592

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  11 in total

1.  Is chloroquine making a comeback?

Authors:  Carla Cerami Hand; Steven R Meshnick
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

2.  In vitro sensitivity of Plasmodium falciparum clinical isolates from the China-Myanmar border area to quinine and association with polymorphism in the Na+/H+ exchanger.

Authors:  Hao Meng; Rongping Zhang; Henglin Yang; Qi Fan; Xinzhuan Su; Jun Miao; Liwang Cui; Zhaoqing Yang
Journal:  Antimicrob Agents Chemother       Date:  2010-07-19       Impact factor: 5.191

Review 3.  Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.

Authors:  Robert L Summers; Megan N Nash; Rowena E Martin
Journal:  Cell Mol Life Sci       Date:  2012-06       Impact factor: 9.261

4.  Plasmodium falciparum multidrug resistance protein 1 (pfmrp1) gene and its association with in vitro drug susceptibility of parasite isolates from north-east Myanmar.

Authors:  Bhavna Gupta; Shuhui Xu; Zenglei Wang; Ling Sun; Jun Miao; Liwang Cui; Zhaoqing Yang
Journal:  J Antimicrob Chemother       Date:  2014-05-22       Impact factor: 5.790

5.  In vitro activities of pyronaridine, alone and in combination with other antimalarial drugs, against Plasmodium falciparum.

Authors:  P Ringwald; E C Eboumbou; J Bickii; L K Basco
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

6.  Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda.

Authors:  Fatima Nawaz; Samuel L Nsobya; Moses Kiggundu; Moses Joloba; Philip J Rosenthal
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

7.  Monitoring Plasmodium falciparum chloroquine resistance in Yunnan Province, China, 1981-2006.

Authors:  Henglin Yang; Yaming Yang; Pinfang Yang; Xingliang Li; Baihe Gao; Zhiyong Zhang; Zhaoqing Yang; Liwang Cui
Journal:  Acta Trop       Date:  2008-09-06       Impact factor: 3.112

Review 8.  Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.

Authors:  Hasifa Bukirwa; B Unnikrishnan; Christine V Kramer; David Sinclair; Suma Nair; Prathap Tharyan
Journal:  Cochrane Database Syst Rev       Date:  2014-03-04

9.  Synergism between pyronaridine and retinol in Plasmodium falciparum in vitro.

Authors:  Pippa Proell; Kanungnit Congpuong; Franz F Reinthaler; Gunther Wernsdorfer; Ursula Wiedermann; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2009-10       Impact factor: 1.704

10.  In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays.

Authors:  Florian Kurth; Peter Pongratz; Sabine Bélard; Benjamin Mordmüller; Peter G Kremsner; Michael Ramharter
Journal:  Malar J       Date:  2009-04-23       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.